Ligand profile
ZINC6484604
Virtual-screening candidate from ZINC.
Bound to: KP13_00024 — ATP synthase gamma chain
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC6484604- UniProt (similar protein)
P05631- Tanimoto
- 0.721
- Target protein
- KP13_00024
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 120.4
- −1 ≤ LogP ≤ 5 2.29
- MW ≤ 500 Da 316.3
- LogP ≤ 5 2.29
- H-bond donors ≤ 5 4
- H-bond acceptors ≤ 10 7
- Rotatable bonds ≤ 10 2
- TPSA ≤ 140 Ų 120.4
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
COc1ccc(-c2oc3cc(O)cc(O)c3c(=O)c2O)cc1OCOc1ccc(-c2oc3cc(O)cc(O)c3c(=O)c2O)cc1O
InChI=1S/C16H12O7/c1-22-11-3-2-7(4-9(11)18)16-15(21)14(20)13-10(19)5-8(17)6-12(13)23-16/h2-6,17-19,21H,1H3InChI=1S/C16H12O7/c1-22-11-3-2-7(4-9(11)18)16-15(21)14(20)13-10(19)5-8(17)6-12(13)23-16/h2-6,17-19,21H,1H3
FPLMIPQZHHQWHN-UHFFFAOYSA-NFPLMIPQZHHQWHN-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- QUE
- Homolog
- P05631
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC6484604 →
- ZINC ZINC20 ZINC6484604 →
- UniProt UniProt P05631 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC6484604”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_00024.
PDB 4
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 1
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).